Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 184938, 8 pages
http://dx.doi.org/10.1155/2015/184938
Research Article

Cardioprotective Effect of Propofol against Oxygen Glucose Deprivation and Reperfusion Injury in H9c2 Cells

1Department of Internal Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
2School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

Received 11 December 2014; Revised 18 February 2015; Accepted 25 February 2015

Academic Editor: Kota V. Ramana

Copyright © 2015 Dandan Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2013 update: a report from the American Heart Association,” Circulation, vol. 127, no. 1, pp. e6–e245, 2013. View at Publisher · View at Google Scholar
  2. B. Halliwell, “Antioxidant characterization. Methodology and mechanism,” Biochemical Pharmacology, vol. 49, no. 10, pp. 1341–1348, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Singh, A. K. Dhalla, C. Seneviratne, and P. K. Singal, “Oxidative stress and heart failure,” Molecular and Cellular Biochemistry, vol. 147, no. 1-2, pp. 77–81, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ramond, D. Godin-Ribuot, C. Ribuot et al., “Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia,” Fundamental & Clinical Pharmacology, vol. 27, no. 3, pp. 252–261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E.-M. Jeong, M. Liu, M. Sturdy et al., “Metabolic stress, reactive oxygen species, and arrhythmia,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 2, pp. 454–463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Wahr, J. Vender, H. C. Gilbert, B. Spiess, J. C. Horrow, and R. Maddi, “Effect of propofol with and without EDTA on haemodynamics and calcium and magnesium homeostasis during and after cardiac surgery,” Intensive Care Medicine, vol. 26, supplement 4, pp. S443–S451, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Vasileiou, T. Xanthos, E. Koudouna et al., “Propofol: a review of its non-anaesthetic effects,” European Journal of Pharmacology, vol. 605, no. 1–3, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Liu, A.-L. Kong, R. Chen et al., “Propofol and arrhythmias: two sides of the coin,” Acta Pharmacologica Sinica, vol. 32, no. 6, pp. 817–823, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Liu, J.-Y. Yao, C. Qian et al., “Effects of propofol on ischemia-induced ventricular arrhythmias and mitochondrial ATP-sensitive potassium channels,” Acta Pharmacologica Sinica, vol. 33, no. 12, pp. 1495–1501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Hans, G. Deby-Dupont, C. Deby et al., “Increase in antioxidant capacity of plasma during propofol anesthesia,” Journal of Neurosurgical Anesthesiology, vol. 9, no. 3, pp. 234–236, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Li, Y. Zhang, Y. Liu et al., “In vitro kinetic evaluation of the free radical scavenging ability of propofol,” Anesthesiology, vol. 116, no. 6, pp. 1258–1266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Xia, D. V. Godin, and D. M. Ansley, “Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F2t-isoprostane formation and tissue antioxidant capacity,” Cardiovascular Research, vol. 59, no. 1, pp. 113–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. B. J. McDermott, S. McWilliams, K. Smyth et al., “Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 3, pp. 600–608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Javadov, K. H. H. Lim, P. M. Kerr, M.-S. Suleiman, G. D. Angelini, and A. P. Halestrap, “Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition,” Cardiovascular Research, vol. 45, no. 2, pp. 360–369, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. C. Jin, W. Kim, Y. M. Ha et al., “Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo,” Vascular Pharmacology, vol. 50, no. 1-2, pp. 71–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Sengupta, V. V. Kalinichenko, and K. E. Yutzey, “FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation,” Circulation Research, vol. 112, no. 2, pp. 267–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. E. L. Greer and A. Brunet, “FOXO transcription factors at the interface between longevity and tumor suppression,” Oncogene, vol. 24, no. 50, pp. 7410–7425, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Inoki, J. Kim, and K.-L. Guan, “AMPK and mTOR in cellular energy homeostasis and drug targets,” Annual Review of Pharmacology and Toxicology, vol. 52, pp. 381–400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Paiva, L. M. Gonçalves, L. A. Providência, S. M. Davidson, D. M. Yellon, and M. M. Mocanu, “Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction,” Cardiovascular Drugs and Therapy, vol. 24, no. 1, pp. 25–32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Lee, K. Kim, Y. H. Kim et al., “Preventive role of propofol in hypoxia/reoxygenation-induced apoptotic H9c2 rat cardiac myoblast cell death,” Molecular Medicine Reports, vol. 4, no. 2, pp. 351–356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Martindale and N. J. Holbrook, “Cellular response to oxidative stress: signaling for suicide and survival,” Journal of Cellular Physiology, vol. 192, no. 1, pp. 1–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. T. A. Rodrigues, R. A. Alexandrino, M. E. Kanczuk, J. L. Gozzani, and L. A. D. S. T. Mathias, “A comparative study of non-lipid nanoemulsion of propofol with solutol and propofol emulsion with lecithin,” Revista Brasileira de Anestesiologia, vol. 62, no. 3, pp. 325–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. L. G. Kevin, E. Novalija, and D. F. Stowe, “Reactive oxygen species is mediators of cardiac injury and protection: the relevance to anesthesia practice,” Anesthesia and Analgesia, vol. 101, no. 5, pp. 1275–1287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Arstall, J. Yang, I. Stafford, W. H. Betts, and J. D. Horowitz, “N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects,” Circulation, vol. 92, no. 10, pp. 2855–2862, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Wang, J. Shravah, H. Luo, K. Raedschelders, D. D. Y. Chen, and D. M. Ansley, “Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation,” Biochemical and Biophysical Research Communications, vol. 389, no. 1, pp. 105–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. B. Becker, “New concepts in reactive oxygen species and cardiovascular reperfusion physiology,” Cardiovascular Research, vol. 61, no. 3, pp. 461–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. V. V. Lakshmi, G. Padmaja, P. Kuppusamy, and V. K. Kutala, “Oxidative stress in cardiovascular disease,” Indian Journal of Biochemistry and Biophysics, vol. 46, no. 6, pp. 421–440, 2009. View at Google Scholar · View at Scopus
  28. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Nielsen, B. B. Mikkelsen, J. B. Nielsen, H. R. Andersen, and P. Grandjean, “Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors,” Clinical Chemistry, vol. 43, no. 7, pp. 1209–1214, 1997. View at Google Scholar · View at Scopus
  30. J. M. Matés, “Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology,” Toxicology, vol. 153, no. 1–3, pp. 83–104, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Vijayasarathy, K. Shanthi Naidu, and B. K. S. Sastry, “Melatonin metabolite 6-Sulfatoxymelatonin, Cu/Zn superoxide dismutase, oxidized LDL and malondialdehyde in unstable angina,” International Journal of Cardiology, vol. 144, no. 2, pp. 315–317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Fridovich, “Superoxide radical and superoxide dismutases,” Annual Review of Biochemistry, vol. 64, pp. 97–112, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. S. L. Marklund, “Human copper-containing superoxide dismutase of high molecular weight,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 24, pp. 7634–7638, 1982. View at Publisher · View at Google Scholar · View at Scopus
  34. J. I. Harris, A. D. Auffret, F. D. Northrop, and J. E. Walker, “Structural comparisons of superoxide dismutases,” FEBS, vol. 106, no. 1, pp. 297–303, 1980. View at Google Scholar · View at Scopus
  35. M. Tanaka, G. K. Mokhtari, R. D. Terry et al., “Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts,” Circulation, vol. 110, no. 11, pp. II200–II206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Giorgio, M. Trinei, E. Migliaccio, and P. G. Pelicci, “Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 722–728, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Huang and D. J. Tindall, “Dynamic FoxO transcription factors,” Journal of Cell Science, vol. 120, no. 15, pp. 2479–2487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. D. A. Salih and A. Brunet, “FoxO transcription factors in the maintenance of cellular homeostasis during aging,” Current Opinion in Cell Biology, vol. 20, no. 2, pp. 126–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. C. W. van den Berg and B. M. T. Burgering, “Integrating opposing signals toward forkhead box O,” Antioxidants and Redox Signaling, vol. 14, no. 4, pp. 607–621, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. K. N. Papanicolaou, Y. Izumiya, and K. Walsh, “Forkhead transcription factors and cardiovascular biology,” Circulation Research, vol. 102, no. 1, pp. 16–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Aoki, H. Jiang, and P. K. Vogt, “Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 37, pp. 13613–13617, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. A. R. Subauste and C. F. Burant, “Role of FoxO1 in FFA-induced oxidative stress in adipocytes,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 293, no. 1, pp. E159–E164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. N. R. Sundaresan, S. A. Samant, V. B. Pillai, S. B. Rajamohan, and M. P. Gupta, “SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70,” Molecular and Cellular Biology, vol. 28, no. 20, pp. 6384–6401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. E. L. Greer, P. R. Oskoui, M. R. Banko et al., “The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor,” The Journal of Biological Chemistry, vol. 282, no. 41, pp. 30107–30119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. X.-N. Li, J. Song, L. Zhang et al., “Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin,” Diabetes, vol. 58, no. 10, pp. 2246–2257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Kudo, A. J. Barr, R. L. Barr, S. Desai, and G. D. Lopaschuk, “High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase,” Journal of Biological Chemistry, vol. 270, no. 29, pp. 17513–17520, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. J. R. B. Dyck and G. D. Lopaschuk, “AMPK alterations in cardiac physiology and pathology: enemy or ally?” The Journal of Physiology, vol. 574, no. 1, pp. 95–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Chang, M. Zhang, J. Li et al., “Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5′-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart,” Cardiovascular Drugs and Therapy, vol. 26, no. 6, pp. 467–478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Asada, H. Daitoku, H. Matsuzaki et al., “Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1,” Cellular Signalling, vol. 19, no. 3, pp. 519–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Kurokawa, P. A. Murray, and D. S. Damron, “Propofol attenuates β-adrenoreceptor-mediated signal transduction via a protein kinase C-dependent pathway in cardiomyocytes,” Anesthesiology, vol. 96, no. 3, pp. 688–698, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Zhang, Y. Dong, Z. Xu, and Z. Xie, “Propofol and magnesium attenuate isoflurane-induced caspase-3 activation via inhibiting mitochondrial permeability transition pore,” Medical Gas Research, vol. 2, article 20, 2012. View at Publisher · View at Google Scholar
  52. Y. Li, Y. J. Liu, G. Lv, D. L. Zhang, L. Zhang, and D. Li, “Propofol protects against hydrogen peroxide-induced apoptosis in cardiac H9c2 cells is associated with the NF-kappaB activation and PUMA expression,” European Review for Medical and Pharmacological Sciences, vol. 18, pp. 1517–1524, 2014. View at Google Scholar